期刊文献+

121例腹腔镜Roux-en-Y胃空肠吻合术后随访结果 被引量:3

Laparoscopic Roux-en-Y gastric bypass for morbid obesity:Follow-up results in 121 patients
下载PDF
导出
摘要 目的探讨腹腔镜Roux-en-Y胃空肠吻合术(laparoscopic Roux-en-Y gastric bypass,LRYGBP)治疗病态肥胖的术后营养和代谢方面的变化。方法121例LRYGBP,男40例,女81例。分别测定术前1个月及术后6个月的体重指数(body mass index,BMI)。对比分析6个月、12个月,24个月血清铁(Fe)、钙(Ca)、锌(Zn)、硒(Se)及维生素A(VitA)、维生素D(VitD)、维生素B12(VitB12)和甲状旁腺素(parathyroid hormone,PTH)的水平变化。结果术前1个月BMI(47.00±7.15)kg/m^2,术后6个月BMI(33.79±6.06)kg/m^2,BMI下降(13.21±5.47)kg/m^2(t=26.103,P=0.000)。术后血清Fe、Ca、Zn、Se及ViLA、VitD、VitB12均在正常范围,其中术后6个月血清Zn、Se和VitA水平虽然在正常范围内,但分别有19.5%(17/87)、22.7%(20/88)和33.7%(28/83)的患者低于正常水平,但术后2年仅有6.7%(2/30)、11.5%(3/26)和17.2%(5/29)的患者低于正常水平。血清PTH术后6个月11~161pg/ml,(66±34)pg/ml、1年24~154pg/ml,(72±34)pg/ml、2年21~194pg/ml,(75±40)pg/ml(正常值9~44pg/ml)。结论LRYGBP治疗病态肥胖是有效、安全的。术后2年血清Fe、Ca及VitD、VitB12均正常;血清锌、硒及维生素A经术后6个月给予补充剂大多接近正常;血清PTH水平明显高于正常。建议患者术后长期服用复合维生素、矿物质补充剂,定期到医院随访。 Objective To summarize the changes of nutrition and metabolism after laparoscopic Roux-en-Y gastric bypass surgery (LRYGBP) in the treatment of morbid obesity. Methods LRYGBP was performed in 121 patients with morbid obesity ( male, 40 patients; femal, 81 patients). The body mass index (BMI) was measured 1 month before and 6 months after the operation. A comparative analysis was conducted on serum levels of ferrum (Fe) , calcium (Ca) , zincum (Zn) , selenium ( Se ) , vitamin A (VitA), vitamin D (VitD), vitamin Bt2 (VitB12), and parathyroid hormone (PTH) at 6, 12, and 24 months after operation. Results The BMI was declined from 47.00 ±7.15 kg/m^2 preoperatively to 33.79 ± 6.06 kg/m^2 postoperatively, with a decrease of 0.26 -42.58 kg/m2 ( 13.21 ± 5.47 kg/m^2 ) (t = 26. 103, P = 0. 001 ). The postoperative serum levels of Fe, Ca, Zn, Se, VitA, VitD, and VitB12 were all within the normal limits. However, the levels of Zn, Se, and VitA were lower than the normal in 19.5% (17/87), 22.7% (20/88), and 3.7% (28/83) of patients at 6 months after operation, and in 6.0% (2/30), 11.5% (3/26), and 17.2% (5/29) of patients at 2 years after operation, respectively. The serum PTH levels were 11 - 161 pg/ml (66 ± 34 pg/ml), 24-154 pg/ml (72 ± 34 pg/ml) , and 21 - 194 pg/ml (75 ±40 pg/ml) at 6, 12, and 24 months after operation, respectively (normal limits, 9 -44 pg/ml ). Conclusions Laparoscopic Roux-en-Y gastric bypass surgery is a reliable and safe option for patients with morbid obesity. The serum levels of calcium, zinc, selenium, and PTH will be influenced following the surgery. Supplementation of multi-vitamins and mineral substances should be strongly advised in all patients.
出处 《中国微创外科杂志》 CSCD 2007年第1期35-37,共3页 Chinese Journal of Minimally Invasive Surgery
关键词 肥胖症 腹腔镜Roux-en-Y胃空肠吻合术 营养 代谢 Obesity Laparoscopy Roux-en-Y gastric bypass surgery Nutrition Metabolism
  • 相关文献

参考文献17

  • 1宫轲.肥胖病的外科治疗[J].中国微创外科杂志,2005,5(4):260-262. 被引量:6
  • 2宫轲,Michel Gagner,Sergio Bardarol,Kazuk Uedal.胃小囊网片包裹术治疗肥胖症的可行性实验研究[J].中国微创外科杂志,2006,6(6):471-473. 被引量:1
  • 3Sugerman HJ,Kellum JM,Engle KM,et al.Gastric bypass for treating severe obesity.Am J Clin Nutr,1992,55(2 Suppl):S560-S566.
  • 4Benotti PN,Forse RA.The role of gastric surgery in the multidisciplinary management of severe obesity.Am J Surg,1995,169(3):361-367.
  • 5Buchwald H,Williams SE.Bariatric surgery worldwide 2003.Obes Surg,2004,14:1157-1164.
  • 6Deitel M,Shikora SA.The development of the surgical treatment of morbid obesity.J Am Coll Nutr,2002,12:365-371.
  • 7El-Kadre LJ,Rocha PR,de-Almeida-Tinoco AC,et al.Calcium metabolism in pre-and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass.Obes Surg,2004,14:1062-1066.
  • 8Fujioka K.Follow-up of nutritional and metabolic problems after bariatric surgery.Diabetes Care,2005,28:481-484.
  • 9MacLean LD,Rhode BM,Shizgal HM,et al.Nutrition following gastric operations for morbid obesity.Ann Surg,1983,198:347-355.
  • 10Amaral JF,Thompson WR,Caldweu MD,et al.Prospective hematologic evaluation of gastric exclusion surgery for morbid obesity.Ann Surg,1985,201(2):186-193.

二级参考文献38

  • 1宫轲.肥胖病的外科治疗[J].中国微创外科杂志,2005,5(4):260-262. 被引量:6
  • 2Christou NV,Sampalis JS,Liberman M, et al. Surgery decreases long-term mortality,morbidity, and health care use in morbidly obese patients. Ann Surg,2004,240:416-424.
  • 3Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000.JAMA,2004,291:1238-1264.
  • 4Would Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Would Health Organ Tech Rep Ser,2000,894:1-253.
  • 5Nguyen NT,Wolfe BM. The physiologic effects of pneumoperitoneum in the morbidly obese. Ann Surg,2005,241:219-226.
  • 6Stam-Moraga MC, Kolanowski J, Kramaix M, et al. Trends in the prevalence of obesity among Belgian men at work, 1977-1992. Int J Obes Relat Metab Disord,1998,22:988-992.
  • 7Ogden CL, Flegal KM, Carroll MD, et al. Prevalence and trend in overweight among US chidren and adolescents, 1999-2000. JAMA,2002,288:1728-1732.
  • 8Balsiger BM, Murr MM, Poggio JL,et al.Bariatric surgery. Surgery for weight control in patients with morbid obesity. Med Clin North Am,2000,84:477-489.
  • 9Thomusch O,Keck T,Dobschütz EV,et al. Risk factors for the intermediate outcome of morbid obesity after laparoscopically placed adjustable gastric banding. Am J Surg,2005,189:214-218.
  • 10RESA JJ,SOLANO J,FATáS JA, et al. Laparoscopic biliopancreatic diversion with distal gastric preservation:technique and three-year follow up. J Laparoendosc Adv Surg Tech A,2004,14:131-134.

共引文献5

同被引文献64

  • 1邹大进.胰高血糖素样多肽-1类似物治疗2型糖尿病的优势与意义[J].中华糖尿病杂志,2009,1(6). 被引量:7
  • 2王存川,杨景哥,陈鋆,胡友主,何家驹,许朋,葛鹏,苏超.腹腔镜Roux-en-Y胃旁路手术治疗肥胖症[J].中华外科杂志,2007,45(5):356-358. 被引量:7
  • 3De Maria EJ,Sugerman HJ,Kellum JM,et al.Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity.Ann Surg,2002,235:640-647.
  • 4Higa KD,Boone KB,Ho T,et al.Laparoscopic Roux-en-Y gastric bypass for morbid obesity:technique and preliminary results of our first 400 patients.Arch Surg,2000,135:1029-1034.
  • 5Chapman AE,Kiroff G,Game P,et al.Laparoscopic adjustable gastric banding in the treatment of obesity:a systematic literature review.Surgery,2004,135:326-351.
  • 6Buchwald H,Avidor Y,Braunwald E,et al.Bariatric surgery:a systematic review and meta-analysis.JAMA,2004,292:1724-1737.
  • 7Buchwald H,Avidor Y,Braunwald E,et al.Bariatric surgery:a systematic review and meta-analysis.JAMA.,2004,292:1724-1737.
  • 8Long SD,O'Brien K,MacDonald KG Jr,et al.Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type Ⅱ diabetes:a longitudinal interventional study.Diabetes Care,1994,17:372-375.
  • 9Friedman NM,Sancetta AJ,Magovern GJ.The amelioration of diabetes mellitus following subtotal gastrectomy.Surg Gynecol Obstetr,955,100:201-204.
  • 10Cohen RV,Schiavon CA,Pinheiro JS,et al.Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2:a report of 2 cases.Surg Obes Related Dis,2007,3:195-197.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部